TE
ABBV icon

Tema ETFs’s AbbVie ABBV Stock Holding History

Tema ETFs’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
61,759
+3,956
+7% +$851K 0.5% 50
2026
Q1 		$12.6M Buy
57,803
+6,014
+12% +$1.33M 0.84% 28
2025
Q4 		$11.8M Buy
51,789
+3,475
+7% +$792K 0.92% 19
2025
Q3 		$11.2M Buy
48,314
+34,948
+261% +$7.12M 0.93% 15
2025
Q2 		$2.48M Sell
13,366
-226
-2% -$42K 0.66% 56
2025
Q1 		$2.85M Buy
+13,592
New +$2.64M 0.85% 38

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tema ETFs's ABBV Position: Q2 2026 in Review

Tema ETFs increased its AbbVie (ABBV) stake by 6.8% in Q2 2026, buying an estimated $851K and bringing the position to 61,759 shares worth $15.5M. The position accounts for 0.5% of the portfolio, ranked #50.

Tema ETFs first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tema ETFs held 61,759 shares of AbbVie worth $15.5M as of Q2 2026.
  • Tema ETFs bought 3,956 AbbVie shares in Q2 2026, an estimated $851K.
  • AbbVie made up 0.5% of Tema ETFs's portfolio in Q2 2026, its #50 holding.
  • Tema ETFs first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.